Clover Health Investments, Corp.

AI-generated fair value estimate for this company.

Method: 10-year unlevered FCF DCF: $74.2M TTM free cash flow base (first sustained positive FCF quarter as Medicare Advantage membership scales); FCF growth 40%/35%/30%/25%/20% years 1-5 tapering to 12%/10%/8%/7%/6% years 6-10; 10% discount rate; 3% terminal growth; $199M net cash (no debt); 530M shares outstanding.

Reasoning: Clover Health just inflected to durable positive free cash flow (TTM FCF $74M vs a loss a year ago) as its Counterpart AI-driven medical cost management improves its MLR while membership keeps growing ~50%+ YoY, so a staged FCF DCF that fades today's triple-digit growth down to a steady-state insurer growth rate captures the turnaround better than a static multiple; net cash and no debt let the full enterprise value flow to equity.